Improved outcomes and economic savings with digital therapeutic, BlueStar®, proven by IBM Watson Health
BlueStar, Welldoc’s FDA-cleared digital therapeutic, provides a clinically effective pathway for evidence-based clinical and economic outcomes. BlueStar is proven to lower hospitalizations and ER visits, with less use of supplies and medications.
Estimated annual healthcare savings per person for the Commercial- and Medicare-insured populations with BlueStar
Welldoc presented results of an economic analysis with IBM Watson Health which demonstrates significant healthcare cost savings through the use of BlueStar.